BRAINSTORM CELL THERAPEUTICS INC. Net Cash Provided by (Used in) Operating Activities, Continuing Operations
BRAINSTORM CELL THERAPEUTICS INC. (BCLI) reported Net Cash Provided by (Used in) Operating Activities, Continuing Operations of $3.84 million for the 3-month period ending 2017-09-30, per its 10-Q filed 2017-10-17.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations · last filed 2017-10-17
- BRAINSTORM CELL THERAPEUTICS INC. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2017-09-30 was $3.84M.
- BRAINSTORM CELL THERAPEUTICS INC. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2017-06-30 was -$1.63M.
- BRAINSTORM CELL THERAPEUTICS INC. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2017-03-31 was -$1.64M.
- BRAINSTORM CELL THERAPEUTICS INC. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2016-12-31 was -$1.20M.
- BRAINSTORM CELL THERAPEUTICS INC. net cash provided by (used in) operating activities, continuing operations for fiscal 2016 was -$5.86M.
- BRAINSTORM CELL THERAPEUTICS INC. net cash provided by (used in) operating activities, continuing operations for fiscal 2015 was -$7.41M.
- BRAINSTORM CELL THERAPEUTICS INC. net cash provided by (used in) operating activities, continuing operations for fiscal 2014 was -$4.49M.
- BRAINSTORM CELL THERAPEUTICS INC. net cash provided by (used in) operating activities, continuing operations for fiscal 2013 was -$4.05M.
| Period end | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 12 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 12 month as first filed | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 129 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 132 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 135 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 138 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 141 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 144 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 147 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 150 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 153 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 156 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 159 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 162 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2017-09-30 | $3.84M 10-Q · filed 2017-10-17 | $2.21M derived: sum of 2 quarters · filed 2017-10-17 | $571.00K 10-Q · filed 2017-10-17 | -$625.00K derived: sum of 4 quarters · filed 2017-10-17 | |||||||||||||
| 2017-06-30 | -$1.63M 10-Q · filed 2017-08-14 | -$3.27M 10-Q · filed 2017-08-14 | -$4.47M derived: sum of 3 quarters · filed 2017-08-14 | -$4.74M derived: sum of 4 quarters · filed 2017-10-17 | |||||||||||||
| 2017-03-31 | -$1.64M 10-Q · filed 2017-05-15 | -$2.84M derived: sum of 2 quarters · filed 2017-05-15 | -$3.11M derived: sum of 3 quarters · filed 2017-10-17 | -$4.52M derived: sum of 4 quarters · filed 2017-10-17 | |||||||||||||
| 2016-12-31 | -$1.20M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-29 | -$1.47M derived: sum of 2 quarters · filed 2017-10-17 | -$2.88M derived: sum of 3 quarters · filed 2017-10-17 | -$5.86M 10-K · filed 2017-03-29 | |||||||||||||
| 2016-09-30 | -$275.00K 10-Q · filed 2017-10-17 | -$1.68M derived: sum of 2 quarters · filed 2017-10-17 | -$4.66M 10-Q · filed 2017-10-17 | -$5.95M derived: sum of 4 quarters · filed 2017-10-17 | |||||||||||||
| 2016-06-30 | -$1.41M 10-Q · filed 2017-08-14 | -$4.39M 10-Q · filed 2017-08-14 | -$5.68M derived: sum of 3 quarters · filed 2017-08-14 | -$8.21M derived: sum of 4 quarters · filed 2017-08-14 | |||||||||||||
| 2016-03-31 | -$2.98M 10-Q · filed 2017-05-15 | -$4.27M derived: sum of 2 quarters · filed 2017-05-15 | -$6.80M derived: sum of 3 quarters · filed 2017-05-15 | -$8.45M derived: sum of 4 quarters · filed 2017-05-15 | |||||||||||||
| 2015-12-31 | -$1.29M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-29 | -$3.82M derived: sum of 2 quarters · filed 2017-03-29 | -$5.47M derived: sum of 3 quarters · filed 2017-03-29 | -$7.41M 10-K · filed 2017-03-29 | |||||||||||||
| 2015-09-30 | -$2.53M 10-Q · filed 2016-11-14 | -$4.18M derived: sum of 2 quarters · filed 2016-11-14 | -$6.12M 10-Q · filed 2016-11-14 | -$8.12M derived: sum of 4 quarters · filed 2016-11-14 | |||||||||||||
| 2015-06-30 | -$1.65M 10-Q · filed 2016-08-11 | -$3.59M 10-Q · filed 2016-08-11 | -$5.59M derived: sum of 3 quarters · filed 2016-08-11 | -$6.71M derived: sum of 4 quarters · filed 2016-08-11 | |||||||||||||
| 2015-03-31 | -$1.94M 10-Q · filed 2016-05-10 | -$3.94M derived: sum of 2 quarters · filed 2016-05-10 | -$5.06M derived: sum of 3 quarters · filed 2016-05-10 | -$6.03M derived: sum of 4 quarters · filed 2016-05-10 | |||||||||||||
| 2014-12-31 | -$2.01M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-09 | -$3.13M derived: sum of 2 quarters · filed 2016-03-09 | -$4.10M derived: sum of 3 quarters · filed 2016-03-09 | -$4.49M 10-K · filed 2016-03-09 | |||||||||||||
| 2014-09-30 | -$1.12M 10-Q · filed 2015-11-16 | -$2.09M derived: sum of 2 quarters · filed 2015-11-16 | -$2.48M 10-Q · filed 2015-11-16 | -$4.09M derived: sum of 4 quarters · filed 2015-11-16 | |||||||||||||
| 2014-06-30 | -$970.00K 10-Q · filed 2015-08-13 | -$1.36M 10-Q · filed 2015-08-13 | -$2.97M derived: sum of 3 quarters · filed 2015-08-13 | -$3.68M derived: sum of 4 quarters · filed 2015-08-13 | |||||||||||||
| 2014-03-31 | -$391.00K 10-Q · filed 2014-05-13 | -$2.00M derived: sum of 2 quarters · filed 2014-05-13 | -$2.71M derived: sum of 3 quarters · filed 2014-05-13 | -$3.77M derived: sum of 4 quarters · filed 2014-05-13 | -$18.71M 10-Q · filed 2014-05-13 | ||||||||||||
| 2013-12-31 | -$1.61M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-27 | -$2.32M derived: sum of 2 quarters · filed 2014-03-27 | -$3.38M derived: sum of 3 quarters · filed 2014-03-27 | -$4.05M 10-K · filed 2014-03-27 | -$18.32M 10-K · filed 2014-03-27 | ||||||||||||
| 2013-09-30 | -$713.00K 10-Q · filed 2013-11-14 | -$1.78M derived: sum of 2 quarters · filed 2013-11-14 | -$2.45M 10-Q · filed 2013-11-14 | -$3.14M derived: sum of 4 quarters · filed 2014-05-13 | -$16.71M 10-Q · filed 2013-11-14 | ||||||||||||
| 2013-06-30 | -$1.06M 10-Q · filed 2013-08-14 | -$1.73M 10-Q · filed 2013-08-14 | -$2.43M derived: sum of 3 quarters · filed 2014-05-13 | -$3.50M derived: sum of 4 quarters · filed 2014-05-13 | -$16.00M 10-Q · filed 2013-08-14 | ||||||||||||
| 2013-03-31 | -$670.00K 10-Q · filed 2014-05-13 | -$1.37M derived: sum of 2 quarters · filed 2014-05-13 | -$2.44M derived: sum of 3 quarters · filed 2014-05-13 | -$2.86M derived: sum of 4 quarters · filed 2014-05-13 | -$14.93M 10-Q · filed 2013-05-09 | ||||||||||||
| 2012-12-31 | -$696.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-27 | -$1.77M derived: sum of 2 quarters · filed 2014-03-27 | -$2.19M derived: sum of 3 quarters · filed 2014-03-27 | -$2.94M 10-K · filed 2014-03-27 | -$2.92M 10-K · filed 2013-03-14 | -$14.26M 10-K · filed 2013-03-14 | |||||||||||
| 2012-09-30 | -$1.07M 10-Q · filed 2013-11-14 | -$1.49M derived: sum of 2 quarters · filed 2013-11-14 | -$2.24M 10-Q · filed 2013-11-14 | -$2.71M derived: sum of 4 quarters · filed 2013-11-14 | -$13.59M 10-Q · filed 2012-11-13 | ||||||||||||
| 2012-06-30 | -$419.00K 10-Q · filed 2013-08-14 | -$1.17M 10-Q · filed 2013-08-14 | -$1.64M derived: sum of 3 quarters · filed 2013-08-14 | -$2.53M derived: sum of 4 quarters · filed 2013-08-14 | -$12.51M 10-Q/A · filed 2012-08-29 | ||||||||||||
| 2012-03-31 | -$746.00K 10-Q · filed 2013-05-09 | -$1.22M derived: sum of 2 quarters · filed 2013-05-09 | -$2.11M derived: sum of 3 quarters · filed 2013-05-09 | -$2.91M derived: sum of 4 quarters · filed 2013-05-09 | -$12.09M 10-Q · filed 2012-05-11 | ||||||||||||
| 2011-12-31 | -$471.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-14 | -$1.37M derived: sum of 2 quarters · filed 2013-03-14 | -$2.17M derived: sum of 3 quarters · filed 2013-03-14 | -$2.22M 10-K · filed 2013-03-14 | -$11.35M 10-K · filed 2012-03-15 | ||||||||||||
| 2011-09-30 | -$897.00K 10-Q · filed 2012-11-13 | -$1.70M derived: sum of 2 quarters · filed 2012-11-13 | -$1.75M 10-Q · filed 2012-11-13 | -$2.30M derived: sum of 4 quarters · filed 2012-11-13 | -$10.88M 10-Q · filed 2011-11-14 | ||||||||||||
| 2011-06-30 | -$800.00K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-08-29 | -$855.00K 10-Q/A · filed 2012-08-29 | -$1.40M derived: sum of 3 quarters · filed 2012-08-29 | -$1.80M derived: sum of 4 quarters · filed 2012-08-29 | -$9.98M 10-Q/A · filed 2011-09-07 | ||||||||||||
| 2011-03-31 | -$55.00K 10-Q · filed 2012-05-11 | -$601.00K derived: sum of 2 quarters · filed 2012-05-11 | -$1.00M derived: sum of 3 quarters · filed 2012-05-11 | ||||||||||||||
| 2010-12-31 | -$546.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-15 | -$946.00K derived: sum of 2 quarters · filed 2012-03-15 | -$2.07M 10-K · filed 2012-03-15 | ||||||||||||||
| 2010-09-30 | -$400.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-14 | -$1.52M 10-Q · filed 2011-11-14 | |||||||||||||||
| 2010-06-30 | -$1.12M 10-Q/A · filed 2011-09-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| Pluri Inc. (PLUR) | $0.014B | ||
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |